Search for dissertations about: "Pulmonary thromboembolism"

Showing result 1 - 5 of 17 swedish dissertations containing the words Pulmonary thromboembolism.

2. 1. Epidemiology of venous thromboembolism with focus on risk markers

   Author : Magdalena Johansson; Lars Johansson; Marcus Lind; Jan-Håkan Jansson; Gerd Lärfars; Umeå universitet; []
   Keywords : MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Venous thromboembolism; venous thrombosis; deep vein thrombosis; pulmonary embolism; incidence; risk markers; diabetes; glucose; alcohol consumption; alcohol dependence; physical activity; medicin; Medicine;

   Abstract : Background: Venous thromboembolism (VTE) is a vascular disease with an incidence of approximately 140 cases per 100,000 person-years in adults. The incidence of VTE has increased over the last decades, and more than 20% of affected individuals die in the first year after diagnosis. READ MORE

4. 2. Venous thromboembolism. Aspects on risk factors, diagnostic tools and treatment with thrombin inhibition

   Author : Karin Wåhlander; Göteborgs universitet; []
   Keywords : deep vein thrombosis; pulmonary embolism; venous thromboembolism; Factor V Leiden; prothrombin gene G20210A; thrombin inhibition; ximelagatran; melagatran; PT; APTT; D-dimer.;

   Abstract : Venous thromboembolism (VTE), comprising deep vein thrombosis (DVT) and pulmonary embolism (PE), is a multifactorial disease. The aims of the present thesis were to investigate Factor V Leiden and prothrombin G20210A mutations as potential risk factors for VTE during and after major surgery, to compare different D-dimer assays and evaluate their usefulness in the diagnosis of DVT, to investigate clinical effects, safety and pharmacokinetic properties of an oral thrombin inhibitor (ximelagatran) when treating VTE and finally to investigate the usefulness of coagulation assays (APTT and PT) during treatment with thrombin inhibition. READ MORE

5. 3. Drug-related morbidity and mortality : Pharmacoepidemiological aspects

   Author : Anna K. Jönsson; Staffan Hägg; Johan Ahlner; Henrik Druid; Jörg Mörland; Linköpings universitet; []
   Keywords : MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Adverse drug reactions; pharmacoepidemiology; antipsychotics; venous; thromboembolism; warfarin; haemorrhage; intoxication; medico-legal autopsies; mortality; Läkemedelsbiverkningar; farmakoepidemiologi; antipsykotika; venös tromboembolism; warfarin; blödning; intoxikation; rättsmedicinska obduktioner; fatal; Clinical pharmacology; Klinisk farmakologi;

   Abstract : Adverse drug reactions (ADRs) constitute a significant health problem with consequences for the patient as well as for society. Suspected ADRs have been reported to occur in about 2-14% of hospitalised patients. In about 5% of deceased hospitalised patients suspected ADRs may have caused or contributed to the fatal outcome. READ MORE

6. 4. On diagnostic procedures in pulmonary embolism

   Author : Mårten Söderberg; Karolinska Institutet; Karolinska Institutet; []
   Keywords : CTPA; D-dimer; deep venous thrombosis; pre-test probability score; pulmonary arteriography; pulmonary embolism; venous thromboembolism; von Willebrand factor antigen; Wells score.;

   Abstract : Pulmonary embolism (PE) and deep venous thrombosis (DVT) are two entities of venous thromboembolism (VTE). PE is a common cause of mortality and morbidity. The symptoms and signs of PE are difficult to interpret, and the diagnosis is difficult to establish. READ MORE

7. 5. Venous thromboembolism: Risk factors, comorbidities, and treatment-associated risk of bleedings

   Author : Katarina Glise Sandblad; Göteborgs universitet; []
   Keywords : MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Venous thromboembolism; Registries; Overweight; Body mass index; Incidence; Cardiovascular disease; Anticoagulants; Apixaban; Rivaroxaban; Warfarin; Hemorrhage;

   Abstract : Background: Venous thromboembolism (VTE) is the third most common cardiovascular disease, consisting mainly of deep vein thrombosis (DVT) and pulmonary embolism (PE). Since VTE often is a preventable disease, knowledge of risk factors is critical. Following a VTE, many patients are subjected to extended anticoagulant treatment. READ MORE